Abstract: The present disclosure promotes distribution of sensor data among a plurality of business operators. A controller that an information processing system according to the present disclosure includes collects first data including a plurality of items and personal information from mobile bodies belonging to a first business operator. The controller converts the first data to second data not being usable to identify individuals. The controller provides data in a range decided based on content of a predetermined data use contract, among the second data, to a second business operator. The controller calculates a consideration for the data that is to be paid by the second business operator, based on a data use record of the second business operator.

Abstract: The present invention relates to a monoclonal antibody or antibody fragment thereof as a human IgG antibody including at least one lysine derivative in a constant region of the human IgG antibody; a modified antibody or antibody fragment thereof, wherein the lysine derivative is modified; a nucleic acid including a nucleotide sequence encoding the antibody or antibody fragment thereof; a vector including the nucleic acid; a transformed cell obtained by introducing the vector into a host cell; a method for producing the antibody or antibody fragment thereof; and a composition containing the antibody or antibody fragment thereof.

Abstract: The present invention relates to a monoclonal antibody or antibody fragment thereof as a human IgG antibody including at least one lysine derivative in a constant region of the human IgG antibody; a modified antibody or antibody fragment thereof, wherein the lysine derivative is modified; a nucleic acid including a nucleotide sequence encoding the antibody or antibody fragment thereof; a vector including the nucleic acid; a transformed cell obtained by introducing the vector into a host cell; a method for producing the antibody or antibody fragment thereof; and a composition containing the antibody or antibody fragment thereof.

Abstract: The present invention relates to a monoclonal antibody or antibody fragment thereof as a human IgG antibody including at least one lysine derivative in a constant region of the human IgG antibody; a modified antibody or antibody fragment thereof, wherein the lysine derivative is modified; a nucleic acid including a nucleotide sequence encoding the antibody or antibody fragment thereof; a vector including the nucleic acid; a transformed cell obtained by introducing the vector into a host cell; a method for producing the antibody or antibody fragment thereof; and a composition containing the antibody or antibody fragment thereof.

Abstract: This invention reduces or prevents a phenomenon where a screen close to a light source becomes yellowed. A liquid crystal display device includes a liquid crystal display panel and a backlight. The backlight includes a light guide plate 10 and white LEDs 21 arrayed in a first direction on a plane of incidence 11 of the light guide plate 10. The white LEDs 21 each includes, in the first direction on a light-emitting surface, a central area occupied by a blue spectrum more densely than at adjacent sides of the central area. Incident plane protrusions 111, each extending in a thickness direction of the light guide plate 10, are formed on a section corresponding to the area having the dense blue spectrum of each LED 21, at the plane of incidence 11 of the light guide plate 10.

Abstract: A display device includes a prism sheet between a display cell and a light guiding plate. The prism sheet includes a plurality of prisms having a constant apex angle continuously arranged in a second direction on a surface thereof opposed to a light-exiting surface of the light guiding plate. Each of ridge lines of the prisms extends in a first direction. Each prism has a first inclined face on a side on which light from the light guiding plate is incident and a second inclined face on a side reflecting the incident light. An area of the first inclined face is made smaller than an area of the second inclined face, and an area of a light-emitting region in the prism sheet is made larger than an area of a non-light-emitting region.

Abstract: The present invention relates to a monoclonal antibody or antibody fragment thereof as a human IgG antibody including at least one lysine derivative in a constant region of the human IgG antibody; a modified antibody or antibody fragment thereof, wherein the lysine derivative is modified; a nucleic acid including a nucleotide sequence encoding the antibody or antibody fragment thereof; a vector including the nucleic acid; a transformed cell obtained by introducing the vector into a host cell; a method for producing the antibody or antibody fragment thereof; and a composition containing the antibody or antibody fragment thereof.

Abstract: The present invention relates to an antibody or antibody fragment comprising novel Cys residue, to which a hydrophilic macromolecular group or amphipathic macromolecular group can be bound at a high efficiency. In addition, the present invention relates to a monoclonal antibody modified product or an antibody fragment modified product in which cysteine residue is chemically modified.

Abstract: To provide a thin liquid crystal display device featuring excellent color reproducibility. The liquid crystal display panel includes: a liquid crystal display panel outputting different colors on a per-pixel basis; and a backlight. The backlight includes: a light source; a light guide; a reflective sheet on a back side of the light guide; and a group of optical sheets including a wavelength converter and disposed between the liquid crystal display panel and the light guide. The wavelength converter has a structure where quantum dots are dispersed in a transparent medium. The wavelength converter is bonded to another optical medium by means of a diffusing adhesive. Nanoparticles for developing Rayleigh scattering are dispersed in the wavelength converter.

Abstract: This invention reduces or prevents a phenomenon where a screen close to a light source becomes yellowed. A liquid crystal display device includes a liquid crystal display panel and a backlight. The backlight includes a light guide plate 10 and white LEDs 21 arrayed in a first direction on a plane of incidence 11 of the light guide plate 10. The white LEDs 21 each includes, in the first direction on a light-emitting surface, a central area occupied by a blue spectrum more densely than at adjacent sides of the central area. Incident plane protrusions 111, each extending in a thickness direction of the light guide plate 10, are formed on a section corresponding to the area having the dense blue spectrum of each LED 21, at the plane of incidence 11 of the light guide plate 10.

Abstract: This invention reduces or prevents a phenomenon where a screen close to a light source becomes yellowed. A liquid crystal display device includes a liquid crystal display panel and a backlight. The backlight includes a light guide plate 10 and white LEDs 21 arrayed in a first direction on a plane of incidence 11 of the light guide plate 10. The white LEDs 21 each includes, in the first direction on a light-emitting surface, a central area occupied by a blue spectrum more densely than at adjacent sides of the central area. Incident plane protrusions 111, each extending in a thickness direction of the light guide plate 10, are formed on a section corresponding to the area having the dense blue spectrum of each LED 21, at the plane of incidence 11 of the light guide plate 10.

Abstract: To provide a thin liquid crystal display device featuring excellent color reproducibility. The liquid crystal display panel includes: a liquid crystal display panel outputting different colors on a per-pixel basis; and a backlight. The backlight includes: a light source; a light guide; a reflective sheet on a back side of the light guide; and a group of optical sheets including a wavelength converter and disposed between the liquid crystal display panel and the light guide. The wavelength converter has a structure where quantum dots are dispersed in a transparent medium. The wavelength converter is bonded to another optical medium by means of a diffusing adhesive. Nanoparticles for developing Rayleigh scattering are dispersed in the wavelength converter.

Abstract: A display device includes a prism sheet between a display cell and a light guiding plate. The prism sheet includes a plurality of prisms having a constant apex angle continuously arranged in a second direction on a surface thereof opposed to a light-exiting surface of the light guiding plate. Each of ridge lines of the prisms extends in a first direction. Each prism has a first inclined face on a side on which light from the light guiding plate is incident and a second inclined face on a side reflecting the incident light. An area of the first inclined face is made smaller than an area of the second inclined face, and an area of a light-emitting region in the prism sheet is made larger than an area of a non-light-emitting region.

Abstract: According to an aspect, a display device includes: an image display panel; and a planar light source including a light guide plate and an edge-lit light source, the light guide plate illuminating the image display panel from a back side, the edge-lit light source including a plurality of light sources arranged facing a plane of incidence; and a controller that controls luminance of each of the light sources independently. The controller stores therein, as lookup tables for the respective light sources, information on light intensity distributions of light that is incident on the light guide plate from the respective light sources and is emitted to a plane of the image display panel from the light guide plate, and controls a light quantity of each of the light sources based on information on an input signal of an image, and on the lookup tables.

Abstract: This invention reduces or prevents a phenomenon where a screen close to a light source becomes yellowed. A liquid crystal display device includes a liquid crystal display panel and a backlight. The backlight includes a light guide plate 10 and white LEDs 21 arrayed in a first direction on a plane of incidence 11 of the light guide plate 10. The white LEDs 21 each includes, in the first direction on a light-emitting surface, a central area occupied by a blue spectrum more densely than at adjacent sides of the central area. Incident plane protrusions 111, each extending in a thickness direction of the light guide plate 10, are formed on a section corresponding to the area having the dense blue spectrum of each LED 21, at the plane of incidence 11 of the light guide plate 10.

Abstract: The present invention relates to an antibody or antibody fragment comprising novel Cys residue, to which a hydrophilic macromolecular group or amphipathic macromolecular group can be bound at a high efficiency. In addition, the present invention relates to a monoclonal antibody modified product or an antibody fragment modified product in which cysteine residue is chemically modified.

Abstract: A liquid crystal display device includes: a light guide plate including a front surface, a back surface and an edge surface, the light guide plate being arranged such that the edge surface faces a light source, the light guide plate internally reflecting light incident from the edge surface and causing surface emission from the front surface; a liquid crystal display panel; and a reflective sheet arranged so as to face the back surface of the light guide plate. The back surface includes a first portion and a second portion. A surface of the second portion is located at a position recessed relatively from a surface of the first portion. The surface of the first portion is a rough surface. The surface of the second portion is a smooth surface. The reflective sheet is in contact with the first portion but avoids contact with the second portion.

Abstract: The present invention relates to an antibody or antibody fragment comprising novel Cys residue, to which a hydrophilic macromolecular group or amphipathic macromolecular group can be bound at a high efficiency. In addition, the present invention relates to a monoclonal antibody modified product or an antibody fragment modified product in which cysteine residue is chemically modified.

Abstract: According to an aspect, a display device includes: an image display panel; and a planar light source including a light guide plate and an edge-lit light source, the light guide plate illuminating the image display panel from a back side, the edge-lit light source including a plurality of light sources arranged facing a plane of incidence; and a controller that controls luminance of each of the light sources independently. The controller stores therein, as lookup tables for the respective light sources, information on light intensity distributions of light that is incident on the light guide plate from the respective light sources and is emitted to a plane of the image display panel from the light guide plate, and controls a light quantity of each of the light sources based on information on an input signal of an image, and on the lookup tables.

Abstract: Provided is a display device including: a light guide plate arranged so that an edge surface thereof is opposed to a light source, the light guide plate being configured to internally reflect light entering from the edge surface to cause planar light emission from a front surface of the light guide plate; and a reflective sheet arranged so as to be opposed to a rear surface of the light guide plate. Irregularities are formed on the front surface. The irregularities are formed to have a shape of a combination of first convex portions and second convex portions, each of the first convex portions including a first ridge line which continuously extends along a first direction corresponding to a light traveling direction, each of the second convex portions including a second ridge line which continuously extends along a second direction intersecting the first direction.